Skip to main content

Published locations for Tocilizumab raises risk of diverticulitis and GI perforation vs. rituximab and abatacept in RA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tocilizumab raises risk of diverticulitis and GI perforation vs. rituximab and abatacept in RA

User login

  • Reset your password
  • /content/tocilizumab-raises-risk-diverticulitis-and-gi-perforation-vs-rituximab-and-abatacept-ra
  • /rheumatology/article/242071/rheumatoid-arthritis/tocilizumab-raises-risk-diverticulitis-and-gi